Accès gratuit
Numéro
J. Soc. Biol.
Volume 203, Numéro 2, 2009
Angiogenèse : de la biologie à la thérapeutique
Page(s) 193 - 195
DOI https://doi.org/10.1051/jbio/2009023
Publié en ligne 16 juin 2009
  • Azoulay D., Adam R., Lemoine A., Bismuth H., Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg, 2000, 232, 777–785. [CrossRef] [PubMed] [Google Scholar]
  • Beck D.E., Cohen Z., Fleshman J.W., Kaufman H.S., van Goor H., Wolff B.G., Adhesion Study Group Steering Comittee. A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon rectum, 2003, 46, 1310–1399. [Google Scholar]
  • Bergers G., Benjamin L.E., Tumorigenesis and the angiogenic swith. Nat Rev Cancer, 2003, 3, 401–410. [Google Scholar]
  • D'Angelica M., Kornprat P., Gonen M., Chung K.Y., Jarnagin W.R., DeMatteo R.P., Fong Y., Kemeny N., Blumgart L.H., Saltz L.B., Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann Surg Oncol, 2007, 14, 759–765. [CrossRef] [PubMed] [Google Scholar]
  • Elias D., De Baere T., Roche A., Ducreux M., Leclere J., Lasser P., During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Brit J Surg, 1999, 86, 784–788. [CrossRef] [Google Scholar]
  • Elias D., Santoro R., Ouellet JF., Osmak L., de Baere T., Roche A., Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. Hepatogastroenterology, 2004, 51, 1788–1791. [PubMed] [Google Scholar]
  • Eveno C., Gaujoux S., Tobelem G., Pocard M., Did animal offer relevant model for Bevacizumab testing ? Br J Cancer, 2008, 99, 1555. [Google Scholar]
  • Lefevre J.H., Rondelli F., Mourra N., Bennis M., Tiret E., Parc R., Parc Y., Lumboaortic and iliac lymphadenectomy for lymph node recurrence of colorectal cancer: prognostic value of the MSI phenotype. Ann Surg Oncol, 2008, 15, 2433–2438. [CrossRef] [PubMed] [Google Scholar]
  • Ma J., Waxman D.J., Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol Cancer Ther, 2008, 7, 3670–3684. [Google Scholar]
  • Morris-Stiff G., Tan Y.M., Vauthey J.N., Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol, 2008, 34, 609–614. [CrossRef] [PubMed] [Google Scholar]
  • Nicoli S., Ribatti D., Cotelli F., Presta M., Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res, 2007, 67, 2927–2931. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Pocard M., Debruyne P., Mareel M., Dutrillaux B., Poupon M.-F., Single alteration of p53 or E-cadherin genes can alter the surgical benefit in an experimental model of colon cancer. Dis Colon Rectum, 2001a, 44, 1106–1112. [CrossRef] [PubMed] [Google Scholar]
  • Pocard M., Vincent-Salomon A., Girodet J., Salmon R.-J., Effects of preoperative chemotherapy on liver function test after hepatectomy. Hepatogastroenterology, 2001b, 48, 1406–1408. [PubMed] [Google Scholar]
  • Ribero D., Wang H., Donadon M., Zorzi D., Thomas M.B., Eng C., Chang D.Z., Curley S.A., Abdalla E.K., Ellis L.M., Vauthey J.N., Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer, 2007, 110, 2761–2767. [CrossRef] [PubMed] [Google Scholar]
  • Willett C.G., Boucher Y., di Tomaso E., Duda D.G., Munn L.L., Tong R.T., et al., Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med, 2004, 10, 145–147. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.